Drug "Reduxine": reviews na ahịa comments

Ibu ibu ndị mmadụ na-emekarị nnọọ mgbagwoju banyere ya ma na-achọ ụdị nile nke ụzọ ifelata: si mfe nke diets na dietary mgbochi pụrụ iche mbadamba. Isiokwu a ga-ekwu okwu dị nnọọ banyere onye dị otú ahụ ọgwụ - a ọgwụ ọjọọ, "Reduxine". Comments na-azụ ahịa na-egosi na ya nwere a mmetụta yiri na ọgwụ "Meridia", na-enye ahụ enterosorbiruyuschee na anorectics mmetụta.

ụgbọelu

Isi nọ n'ọrụ mgwa nke pharmaceuticals "Reduxine" - sibutramine, nke na-enye a mgbochi nke reuptake nke nọrepinefrini na serotonin. N'okpuru ihe nke sibutramine ọdịnaya na-abawanye neurotransmitters na synapses-abawanye na adrenergic ọrụ na etiti serotonin anabata, nke na-eme ka onye a mmetụta nke satiety, ebelata mkpa nri na enwekwu ọnụ ọgụgụ termoproduktsii. Eziokwu a na-egosi na ọtụtụ ndị na-ahapụ ka ọgwụ "Reduxine 'reviews na-ekwu.

Ke adianade do, sibutramine emetụta aja aja adipose anụ ahụ, rụọ ọrụ B3-adrenergic anabata. Site na mbenata arọ ahụ na ọbara mgbe amụba ịta nke HDL na-ebelata ego nke ngụkọta cholesterol, uric acid, triglycerides na LDL.

Ọzọ integral akụrụngwa "Reduxine" agwọ ọrịa bụ microcrystalline cellulose na-eje ozi dị ka enterosorbent. Ọ nwere mmetụta nke detoxication na sorption Njirimara, na mwepụ na-akwalite nkịtị dị iche iche microorganisms, ha metabolic na ngwaahịa, xenobiotics, nsí endogenous na exogenous uwa, allergens, nakwa dị ka ụfọdụ ngafe metabolites na metabolic na ngwaahịa na-ahụ maka onye ahụ nke endogenous toxicosis.

Egosi maka ojiji

Dị nnọọ ole na ole ndị na-egosi na ngwa na-akọwa mmasị ka ọgwụ ọjọọ, "Reduxine" ntụziaka. Of na-eji ọkụ na-ekwu na e kenyere na agwọ ọrịa maka ọgwụgwọ nke alimentary ibu oké ibu na ihe index nke 30 kg / m2 arọ ahụ ma ọ bụ karịa. Ọ bụrụ na e nwere dị iche iche ihe ize ndụ ihe dị ka isi lipid metabolism (dislipoproteinemia) ma ọ bụ ụdị 2 ọrịa shuga, i nwere ike na-a ọgwụ na a aru uka index 27 kg / m2.

contraindications

Ụfọdụ ndị chọrọ ifelata na iji ọgwụ ọjọọ, "Reduxine 'reviews na-ekwu ekpe iji ịme ọzọ na-eji ọkụ na contraindications. N'etiti ha, e depụtara: uche na-abata nke ọgwụ mmiri, echiche ọrịa, organic akpata oké ibu (e.g., hypothyroidism), ịrịba nsogbu iri (bulimia nervosa ma ọ bụ anorexia), imekotaotuugbo pharmaceuticals na-emetụta ndị CNS, n'akuku-mmechi glaucoma, thyrotoxicosis.

mmetụta

Mgbe ụfọdụ, ị pụrụ ịhụ na njikere nke "Reduxine" na-adịghị mma nzaghachi. Ọtụtụ mgbe ha na-metụtara mmetụta nke a na-emepụta ọgwụ. N'etiti ha bụ ndị ezi mgbe ime: ntachi, akọrọ ọnụ, ehighị ụra nke ọma, na ọnwụ nke agụụ. More adịkarịghị kwuru, sị: palpitations, tachycardia, elu ọbara mgbali, isi ọwụwa, nchegbu, dizziness, mgbanwe uto, sweating na ọgbụgbọ. Nnọọ adịkarịghị gosipụtara clinically ịrịba oghom mmetụta, dị ka flu-dị ka syndrome, dysmenorrhea, anụ itching, ihe mgbu na azụ ma ọ bụ na afo, edema, rhinitis, akpịrị ịkpọ nkụ, ịda mbà n'obi, nchegbu, iro ụra, ahụ ịma jijiji, ahụ mgbakasị, ụfụ, na ọbụna na-agba ọbara.

Drug "Reduxine" na afọ ime

Ndi nke nwunye na-ede banyere nkà mmụta ọgwụ "Reduxine 'reviews na kwuru, mara na o nwere ike ọ gaghị eji ma ọ bụrụ na nwaanyị na-ara a nwa ma ọ bụ dị ime.